We recently compiled a list of 11 Best Future Stocks to Buy Now. Ultragenyx Pharmaceutical Inc. stands first on our list.

Tidmarsh will temporarily guide CBER’s regulatory activities while the FDA searches for a permanent department lead.

After a decade of development, a Kansas City-based pharmaceutical company is on the brink of submitting its ADHD medication ...

Moderna announced layoffs affecting 10% of its workforce amid government and competitive challenges to its vaccine business ...

Oral, non-opioid drug candidate advancing through Phase 1 and nearing completion of the single ascending dose (SAD) portion ...

The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program. Dr.

Analysts say the departure of the CBER head may alleviate overhang in the cell and gene therapy space. Vinay Prasad, head of the Center for Biologics Evaluation and Research (CBER) at the US Food and ...

Speakers at a congressional briefing on July 22 called on the FDA to take action against the marketing and distribution of ...

Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is ...

AbbVie, Bristol Myers Squibb and Eli Lilly appear “relatively well-positioned,” while Novartis and Roche look more at risk, ...

FDA inspections in India have been accelerating, but 160 plants are overdue, including some which haven't been inspected since 2015, yet continue shipping pain pills, antibiotics, and other ...